News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
622,307 Results
Type
Article (48014)
Company Profile (394)
Press Release (573899)
Multimedia
Podcasts (98)
Webinars (12)
Section
Business (162754)
Career Advice (3074)
Deals (29965)
Drug Delivery (109)
Drug Development (79183)
Employer Resources (176)
FDA (15104)
Job Trends (13203)
News (292582)
Policy (28674)
Tag
Academia (2757)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (43547)
ALS (100)
Alzheimer's disease (1443)
Antibody-drug conjugate (ADC) (151)
Approvals (15071)
Artificial intelligence (270)
Autoimmune disease (28)
Automation (14)
Bankruptcy (291)
Best Places to Work (10931)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (304)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (300)
Cancer (2380)
Cardiovascular disease (194)
Career advice (2592)
Career pathing (33)
CAR-T (176)
Cell therapy (494)
Cervical cancer (20)
Clinical research (64303)
Collaboration (892)
Company closure (2)
Compensation (528)
Complete response letters (27)
COVID-19 (2539)
CRISPR (50)
C-suite (262)
Cystic fibrosis (109)
Data (2320)
Decentralized trials (2)
Denatured (30)
Depression (54)
Diabetes (284)
Diagnostics (5595)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (128)
Drug pricing (107)
Drug shortages (31)
Duchenne muscular dystrophy (104)
Earnings (61410)
Editorial (45)
Employer branding (22)
Employer resources (153)
Events (105651)
Executive appointments (716)
FDA (16444)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (122)
Generative AI (24)
Gene therapy (364)
GLP-1 (766)
Government (4358)
Grass and pollen (5)
Guidances (135)
Healthcare (18241)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (141)
Indications (30)
Infectious disease (2677)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (98)
Interviews (600)
IPO (14544)
IRA (43)
Job creations (2720)
Job search strategy (2120)
Kidney cancer (10)
Labor market (40)
Layoffs (454)
Leadership (23)
Legal (5975)
Liver cancer (74)
Lung cancer (331)
Lymphoma (157)
Machine learning (9)
Management (62)
Manufacturing (336)
MASH (77)
Medical device (11698)
Medtech (11701)
Mergers & acquisitions (16027)
Metabolic disorders (748)
Multiple sclerosis (82)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2029)
NextGen: Class of 2025 (6297)
Non-profit (4617)
Now hiring (31)
Obesity (400)
Opinion (261)
Ovarian cancer (81)
Pain (103)
Pancreatic cancer (81)
Parkinson's disease (157)
Partnered (20)
Patents (238)
Patient recruitment (114)
Peanut (49)
People (48443)
Pharmaceutical (78)
Pharmacy benefit managers (21)
Phase I (20222)
Phase II (28490)
Phase III (21163)
Pipeline (1339)
Policy (157)
Postmarket research (2308)
Preclinical (8596)
Press Release (67)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (266)
Rare diseases (427)
Real estate (4954)
Recruiting (70)
Regulatory (20509)
Reports (36)
Research institute (2393)
Resumes & cover letters (494)
Rett syndrome (5)
RNA editing (5)
RSV (40)
Schizophrenia (79)
Series A (134)
Series B (90)
Service/supplier (9)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3249)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (42)
The Weekly (67)
Vaccines (683)
Venture capitalists (43)
Weight loss (273)
Women's health (31)
Worklife (20)
Date
Today (219)
Last 7 days (914)
Last 30 days (3026)
Last 365 days (32390)
2025 (11583)
2024 (34781)
2023 (38992)
2022 (49057)
2021 (53236)
2020 (50988)
2019 (44057)
2018 (33309)
2017 (30660)
2016 (30145)
2015 (34623)
2014 (26771)
2013 (21677)
2012 (22715)
2011 (23323)
2010 (21181)
Location
Africa (850)
Alabama (54)
Alaska (7)
Arizona (168)
Arkansas (14)
Asia (36534)
Australia (6426)
California (6192)
Canada (1977)
China (542)
Colorado (261)
Connecticut (272)
Delaware (153)
Europe (85179)
Florida (903)
Georgia (203)
Idaho (53)
Illinois (546)
India (26)
Indiana (283)
Iowa (12)
Japan (167)
Kansas (102)
Kentucky (26)
Louisiana (12)
Maine (44)
Maryland (865)
Massachusetts (4807)
Michigan (212)
Minnesota (366)
Mississippi (1)
Missouri (80)
Montana (26)
Nebraska (21)
Nevada (55)
New Hampshire (62)
New Jersey (1741)
New Mexico (29)
New York (1754)
North Carolina (1008)
North Dakota (8)
Northern California (2708)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1376)
Puerto Rico (11)
Rhode Island (32)
South America (1132)
South Carolina (23)
South Dakota (1)
Southern California (2327)
Tennessee (77)
Texas (891)
United States (23253)
Utah (163)
Virginia (151)
Washington D.C. (63)
Washington State (575)
West Virginia (3)
Wisconsin (50)
622,307 Results for "the angiogenesis foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
February 3, 2025
·
2 min read
Press Releases
Ashvattha to Present at Upcoming Angiogenesis, Exudation, and Degeneration 2025 and BIO CEO Conferences
February 6, 2025
·
2 min read
Press Releases
Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
February 10, 2025
·
3 min read
Business
Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
Ceapro Inc. announced today the expansion of its collaboration with the Angiogenesis Foundation to conduct research on characterizing healing dynamics and molecular profiling of tissue regeneration stimulated by oat-derived bioactives.
July 18, 2023
·
3 min read
Press Releases
n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
May 8, 2025
·
5 min read
Press Releases
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
·
8 min read
Press Releases
Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting
February 10, 2025
·
9 min read
Press Releases
CTNNB1 Foundation awarded €1M as Slovenia backs nonprofit gene therapy - a first step toward equitable cures for rare diseases
March 31, 2025
·
1 min read
Press Releases
Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
April 28, 2025
·
4 min read
Press Releases
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025
March 31, 2025
·
15 min read
1 of 62,231
Next
